JUN and neoplasm: Further genetic ablation experiments demonstrated that c-Jun in cDCs functioned downstream of TLR7 signaling to mediate the antitumor effect of IL-12 while simultaneously inducing the secretion of CCL2, which recruited pDCs to the TME for direct tumor suppression (Figure E and H).